The IGF-1Rβ/AKT axis was shown to get activated in bone-seeking breast cancer cells after the knockdown of the transcription factor of osteogenic differentiation, namely runt-related transcription factor 2 (RUNX2). This evidence concerns the gene RUNX2 and breast cancer.